All In Biotech

Free tool

FAERS Monitor: Fosamax Plus D

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021762 or its brand name (Fosamax Plus D, Alendronate Sodium, Cholecalciferol). Reports on generic versions are filed under their own applications.

Reports

2,769

Serious

2,562

93% of reports

Hospitalization

1,734

Death reported

128

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • femur fracture1,410
  • fall811
  • osteoarthritis657
  • low turnover osteopathy622
  • hypertension552
  • arthralgia467
  • gastrooesophageal reflux disease438
  • intramedullary rod insertion429
  • osteoporosis428
  • depression406
  • anxiety404
  • pain in extremity397
  • back pain389
  • stress fracture323
  • hyperlipidaemia304

Reports by year received

View as table
YearReports
20052
200649
2007101
2008218
2009205
2010223
2011291
2012772
2013286
2014166
2015123
201672
201740
201850
201927
202024
202143
202228
202318
202413
20258
202610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,390 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
intramedullary rod insertionSignal4292010.81820.0679,991
low turnover osteopathySignal6221400.31296.5733,415
stress fractureSignal323483.6434.9145,832
femur fractureSignal1,410362.3348.7485,264
hyperlipidaemiaSignal304198.4178.158,025
osteoarthritisSignal657119.5111.776,059
osteoporosisSignal42879.973.232,970
gastrooesophageal reflux diseaseSignal43841.538.117,264
hypertensionSignal55219.818.49,935
fallSignal81118.617.513,633
depressionSignal40613.612.44,760
back painSignal38912.711.64,236
anxietySignal40410.89.93,625
pain in extremitySignal39710.29.43,346
arthralgiaSignal4678.57.93,160

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.